Cardiac Rhythm News Issue 23 – January 2014

247

Highlights:
-Largest anticoagulant trial in atrial fibrillation shows edoxaban is as effective as warfarin
-New generation pacemakers reduce atrial fibrillation progression by 61% at two years
-Ablation of persistent atrial fibrillation, are we there yet?
-Profile: Anne Curtis

 

(Visited 18 times, 1 visits today)